Clinical Trial Update: A Clinical Study to Evaluate SM17 for Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SM17 for atopic dermatitis is currently recruiting; no results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SM17

Snippet

Sponsor: SinoMab BioScience Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING